Dialysis-Related Amyloidosis Treatment Act of 2025
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 3
- Latest action
- Jun 20, 2025
What it does
The Dialysis-Related Amyloidosis Treatment Act of 2025 would amend the Social Security Act to provide Medicare coverage and separate payment for FDA-approved treatments for dialysis-related amyloidosis when furnished in dialysis facilities. It defines such treatments as items or services approved by the FDA for this condition, including necessary adjunct supplies or services, and explicitly excludes them from being bundled into renal dialysis service payments. The bill requires that payment for these treatments be made separately at 100% of reasonable charges, effective upon enactment. It affects Medicare beneficiaries receiving dialysis who may develop dialysis-related amyloidosis and the…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.